CRISPR-engineered T cells in patients with refractory cancer
CRISPR takes first steps in humans CRISPR-Cas9 is a revolutionary gene-editing technology that offers the potential to treat diseases such as cancer, but the effects of CRISPR i...
Publications
2 shownChimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whet...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 4,743
- Institution
- University of Pennsylvania
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.